Corcept Therapeutics reported $26.49M in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -33.57M 79M
Ardelyx ARDX:US $ -26.93M 1.14M
Aurora Cannabis Inc ACB:CN -1012377000 936.87M
Biomarin Pharmaceutical BMRN:US $ 34.85M 8.66M
Canopy Growth Corp WEED:CN C$ -2083807000 1.5B
Eleven Biotherapeutics EBIO:US $ -0.81M 9.75M
Esperion Therapeutics ESPR:US $ -66324000 9.59M
Lannett LCI:US $ -22.31M 0.82M
Lexicon Pharmaceuticals LXRX:US $ -24587000 1.11M
Nektar Therapeutics NKTR:US $ -158.97M 68.7M
Novartis NOVN:VX SF 4129M 217M
Novartis NVS:US $ 4129M 217M
Supernus Pharmaceuticals SUPN:US $ 11.32M 3.4M
Tg Therapeutics TGTX:US $ -40.51M 28.5M
Ziopharm Oncology ZIOP:US $ -9.79M 2M